Papers

8

Total Citations

302

H-Index

8

About

Dr. Larry Goldenberg is a pioneering urologic surgeon and researcher whose work has fundamentally shaped the modern treatment of prostate cancer and benign prostatic hyperplasia (BPH). His research centers on three key areas: robotic-assisted surgical techniques, novel minimally invasive therapies for BPH, and the critical relationship between surgeon performance and patient outcomes. Dr. Goldenberg has been instrumental in advancing Aquablation therapy, demonstrating its safety and efficacy for treating large prostates (80-150 cc) through landmark studies like the WATER and WATER II trials, which have collectively garnered over 100 citations. He also developed a groundbreaking robotic transrectal ultrasound system for real-time image guidance during radical prostatectomy, a contribution that has been cited more than 70 times. Notably, his 2017 study on surgeon performance as a predictor of early continence after robot-assisted prostatectomy (75 citations) has become a cornerstone in understanding how technical skill directly impacts patient recovery. Through his leadership at the University of British Columbia, Dr. Goldenberg has not only advanced surgical innovation but also shaped the training of the next generation of urologists, as reflected in his work on robotic surgery education among Canadian residents.

Research Focus

Key Achievements

8
H-Index
8
Papers
302
Total Citations
38
Avg Citations/Paper
🏆 Most Cited Paper
Surgeon Performance Predicts Early Continence After Robot-Assisted Radical Prostatectomy
75 citations · 2017
📈 Most Prolific Year: 2014 (2 Papers)
🤝 Key Collaborators: 48
🏛 Institutions: University of Toronto, University of British Columbia, Vancouver General Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago